Frontier Investment Management’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,210
Closed -$231K 330
2019
Q4
$231K Hold
1,210
0.01% 291
2019
Q3
$204K Buy
+1,210
New +$204K 0.01% 269
2018
Q2
Sell
-13,592
Closed -$2.29M 268
2018
Q1
$2.29M Sell
13,592
-1,361
-9% -$229K 0.19% 85
2017
Q4
$2.45M Sell
14,953
-15,186
-50% -$2.48M 0.2% 88
2017
Q3
$6.18M Buy
30,139
+147
+0.5% +$30.1K 0.51% 52
2017
Q2
$7.29M Sell
29,992
-362
-1% -$88K 0.68% 45
2017
Q1
$7.25M Sell
30,354
-8,710
-22% -$2.08M 0.7% 39
2016
Q4
$8.2M Sell
39,064
-1,600
-4% -$336K 0.78% 32
2016
Q3
$93.7M Buy
40,664
+7,906
+24% +$18.2M 0.82% 26
2016
Q2
$7.57M Buy
+32,758
New +$7.57M 0.94% 31

Other funds holding AGN

Frontier Investment Management's AGN Position: Q1 2020 in Review

Frontier Investment Management sold out of Allergan Inc (AGN) in Q1 2020, closing a stake of 1,210 shares — an estimated $231K sold.

Frontier Investment Management first reported a position in AGN in Q2 2016 and held it in 10 quarters. The position peaked at $93.7M in Q3 2016. 9 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Frontier Investment Management reported no remaining Allergan Inc position as of Q1 2020 after selling out during the quarter.
  • Frontier Investment Management sold 1,210 Allergan Inc shares in Q1 2020, an estimated $231K.
  • Frontier Investment Management first reported a position in Allergan Inc in Q2 2016 and held it in 10 quarters.
  • Frontier Investment Management's Allergan Inc position peaked at $93.7M in Q3 2016.
  • 9 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2020.

Based on Frontier Investment Management's 13F filing for Q1 2020, filed 5 May 2020.